(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl benzoate

• ChemBase ID: 130467
• Molecular Formular: C45H57NO14
• Molecular Mass: 835.93238
• Monoisotopic Mass: 835.37790551
• SMILES: O=C(OC(C)(C)C)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@@H]1C(=C2[C@@H](OC)C(=O)[C@]3([C@H]([C@H](OC(=O)c4ccccc4)[C@@](O)(C2(C)C)C1)[C@@]1(OC(=O)C)[C@H](OC1)C[C@@H]3OC)C)C
• Canonical SMILES: CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@@H]3[C@]([C@H]2[C@@H]([C@]2(C(C1=C(C)[C@@H](OC(=O)[C@@H]([C@H](c1ccccc1)NC(=O)OC(C)(C)C)O)C2)(C)C)O)OC(=O)c1ccccc1)(CO3)OC(=O)C
• InChI: InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1
• InChIKey: BMQGVNUXMIRLCK-OAGWZNDDSA-N

NAMES AND DATABASE IDS

Names

• IUPAC name: (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^3,^1^0.0^4,^7]heptadec-13-en-2-yl benzoate
• IUPAC Traditional name: cabazitaxel
• Brand Name: Jevtana
• Synonyms: Cabazitaxel

Database IDs

• CAS Number: 183133-96-2
• PubChem SID: 162224746
• PubChem CID: 9854073
• CHEBI ID: 63584
• ATC CODE: L01CD04
• CHEMBL: 1201748
• Chemspider ID: 8029779
• DrugBank ID: DB06772
• Unique Ingredient Identifier: 51F690397J
• Wikipedia Title: Cabazitaxel
• Medline Plus: a611009

CALCULATED PROPERTIES

• Acid pKa: 11.967099
• H Acceptors: 10
• H Donor: 3
• LogD (pH = 5.5): 4.203044
• LogD (pH = 7.4): 4.2030325
• Log P: 4.203044
• Molar Refractivity: 213.4041 cm^3
• Polarizability: 85.22958 Å^3
• Polar Surface Area: 202.45 Å^2
• Rotatable Bonds: 15
• Lipinski's Rule of Five: false

PROPERTIES

Pharmacology Properties

• Admin Routes: Intravenous
• Legal Status: POM (UK); Rx-only (US)
• Pregnancy Category: D (US)
• US Licence: Cabazitaxel
• EU Licence: Jevtana